☰

Nathanael Gray

Affiliations: 
Harvard University, Cambridge, MA, United States 
Area:
Cell Biology, Organic Chemistry, Biochemistry
Google:
"Nathanael Gray"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Peter G. Schultz grad student 1994-1998 UC Berkeley

Children

Sign in to add trainee
Yina Li research assistant 2014- Dana-Farber Cancer Institute
Liv H. Johannessen grad student
Qingsong Liu grad student Dana Farber Cancer Institute
Zainab Doctor grad student 2014- Harvard
Benika J. Pinch grad student 2014- Harvard
Chelsea E. Powell grad student 2014- Harvard
Sindhu Carmen Sivakumaren grad student 2014- Harvard Medical School/Dana-Farber Cancer Institute
Dennis E. Dobrovolsky grad student 2015- Harvard
Jaebong Jang post-doc
Yuan Xiong post-doc
Michael E. Pacold post-doc 2010- Dana Farber Cancer Institute
Christopher Michael Browne post-doc 2014- Harvard Medical School/Dana-Farber Cancer Institute
Calla M. Olson post-doc 2014-
Guangyan Du post-doc 2015- Harvard Medical School/Dana-Farber Cancer Institute
Fleur M. Ferguson post-doc 2015- Harvard Medical School/Dana-Farber Cancer Institute
Baishan Jiang post-doc 2015- Harvard Medical School/Dana-Farber Cancer Institute
Suman Rao post-doc 2015- Harvard Medical School/Dana-Farber Cancer Institute
Mei Zeng post-doc 2015-
Dries JH De Clercq post-doc 2016- Dana-Farber Cancer Institute and Harvard Medical School
Yao Liu post-doc 2016- Dana-Farber Cancer Institute and Harvard Medical School
Xianming DENG post-doc 2006-2012 Harvard Medical School, Dana Farber Cancer Institute
Sivapriya Kirubakaran post-doc 2010-2012 Dana Farber Cancer Institute, Harvard Medical School
Carson Thoreen post-doc 2011-2013 Harvard
Kenneth D. Westover post-doc 2012-2014 Harvard
John M. Hatcher post-doc 2012-2015 Harvard Medical School/Dana-Farber Cancer Institute
Spandan Chennamadhavuni post-doc 2014-2015
Quan Cai post-doc 2016-2017 Harvard Medical School/Dana-Farber Cancer Institute
Mingxing Teng post-doc 2018-2022 Dana-Farber Cancer Institute, Harvard Medical School
Jinhua Wang research scientist 2008- Dana-Farber Cancer Institute and Harvard Medical School
Thomas W. Gero research scientist 2015- Dana Farber Cancer Institute
John M. Hatcher research scientist 2015- Harvard Medical School/Dana-Farber Cancer Institute
Sara J. Buhrlage research scientist 2010-2015 Harvard Medical School/Dana-Farber Cancer Institute

Collaborators

Sign in to add collaborator
Sourav Banerjee collaborator
Jinwei Zhang collaborator 2011-2015 Harvard University, Cambridge, MA, United States (Chemistry Tree) (Physiology Academic Tree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lantermans HC, Ma F, Kuil A, et al. (2024) The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma. Leukemia
Erickson EC, You I, Perry G, et al. (2024) Multiomic profiling of breast cancer cells uncovers stress MAPK-associated sensitivity to AKT degradation. Science Signaling. 17: eadf2670
Li Z, Lu W, Beyett TS, et al. (2024) ZNL0325, a Pyrazolopyrimidine-Based Covalent Probe, Demonstrates an Alternative Binding Mode for Kinases. Journal of Medicinal Chemistry
Wang L, Bohmer MJ, Wang J, et al. (2024) Discovery of Potent Antimalarial Type II Kinase Inhibitors with Selectivity over Human Kinases. Journal of Medicinal Chemistry
Sarott R, Gourisankar S, Karim B, et al. (2023) Borrowing Transcriptional Kinases to Activate Apoptosis. Biorxiv : the Preprint Server For Biology
Hassan MM, Li YD, Ma MW, et al. (2023) Exploration of the Tunability of BRD4 Degradation by DCAF16 -labelling Covalent Glues. Biorxiv : the Preprint Server For Biology
Mukhopadhyay S, Huang HY, Lin Z, et al. (2023) Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy. Cancer Research
Hatcher JM, Zwirek M, Sarhan AR, et al. (2023) Development of a Highly Potent and Selective Degrader of LRRK2. Bioorganic & Medicinal Chemistry Letters. 129449
Kim Y, Seo P, Jeon E, et al. (2023) Targeted kinase degradation via the KLHDC2 ubiquitin E3 ligase. Cell Chemical Biology
Teng M, Gray NS. (2023) The rise of degrader drugs. Cell Chemical Biology. 30: 864-878
See more...